English

简体中文 English

ABOUT US

Weihai Ziguang was founded in 1997 and is located in Weihai, Shandong, which is the most beautiful coastal city for human habitation; The registered capital of the company is 200 million yuan, covering an area of over 1600 acres, and currently employs more than 1200 people; We have five major industrial bases, including a comprehensive health product intelligent industry base, a full cycle health and wellness industry base, a fine chemical industry base, a fig industry research and development base, and a health and leisure food deep processing base, as well as two major basic centers in Shandong Province, including a key research and development center and a testing center. We have 42 automated production lines for full dosage forms such as tablets, soft and hard capsules, powders, water, soft candy, and explosive beads, with a professional workshop area of over 30000 square meters and an annual production capacity of over 6 billion yuan;

The company has been deeply involved in the health food industry for 28 years since its establishment, while relying on its strong research and development capabilities to vigorously develop multiple health categories such as functional foods, special medical meals, and medicinal food homology. It has successively passed GMP ISO, HACCP, CNAS, FDA, and more than 17 domestic and foreign certifications have been obtained, with over 1600 nutrition and health food registration numbers. Our business scope covers the world, with over 10000 partners and over 200000 radiation terminals. We have become a comprehensive, safe, reliable, and trustworthy professional service provider for nutrition and health food in China.

1580 Chengda Road, Jingji District, Weihai City, Shandong Province
0631-5387814
ziguangyoujian@163.com

Policy background

visits： Release time2024-05-10

————The 13th Five Year Plan for the Development of National Strategic Emerging Industries

Develop therapeutic vaccines, RNA interference drugs, aptamer drugs, as well as stem cell therapy, CAR-T cell immunotherapy, and other biological therapy products.